BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34482176)

  • 1. Iodine concentration and tissue attenuation in dual-energy contrast-enhanced CT as a potential quantitative parameter in early detection of local pancreatic carcinoma recurrence after surgical resection.
    Mathy RM; Fritz F; Mayer P; Klauss M; Grenacher L; Stiller W; Kauczor HU; Skornitzke S
    Eur J Radiol; 2021 Oct; 143():109944. PubMed ID: 34482176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
    Stiller W; Skornitzke S; Fritz F; Klauss M; Hansen J; Pahn G; Grenacher L; Kauczor HU
    Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma.
    Parakh A; Patino M; Muenzel D; Kambadakone A; Sahani DV
    Abdom Radiol (NY); 2018 Feb; 43(2):497-504. PubMed ID: 29138890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Energy Perfusion-CT in Recurrent Pancreatic Cancer - Preliminary Results.
    Fritz F; Skornitzke S; Hackert T; Kauczor HU; Stiller W; Grenacher L; Klauss M
    Rofo; 2016 Jun; 188(6):559-65. PubMed ID: 27224576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.
    Skornitzke S; Fritz F; Mayer P; Koell M; Hansen J; Pahn G; Hackert T; Kauczor HU; Stiller W
    Br J Radiol; 2018 May; 91(1085):20170351. PubMed ID: 29446319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring Dynamic CT Perfusion Based on Time-Resolved Quantitative DECT Iodine Maps: Comparison to Conventional Perfusion at 80 kVp for Pancreatic Carcinoma.
    Skornitzke S; Kauczor HU; Stiller W
    Invest Radiol; 2019 Nov; 54(11):689-696. PubMed ID: 31335633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image quality of mean temporal arterial and mean temporal portal venous phase images calculated from low dose dynamic volume perfusion CT datasets in patients with hepatocellular carcinoma and pancreatic cancer.
    Wang X; Henzler T; Gawlitza J; Diehl S; Wilhelm T; Schoenberg SO; Jin ZY; Xue HD; Smakic A
    Eur J Radiol; 2016 Nov; 85(11):2104-2110. PubMed ID: 27776665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC.
    Pfeiffer D; Parakh A; Patino M; Kambadakone A; Rummeny EJ; Sahani DV
    Abdom Radiol (NY); 2018 Dec; 43(12):3317-3323. PubMed ID: 29774382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-source dual-energy CT angiography with virtual non-enhanced images and iodine map for active gastrointestinal bleeding: image quality, radiation dose and diagnostic performance.
    Sun H; Hou XY; Xue HD; Li XG; Jin ZY; Qian JM; Yu JC; Zhu HD
    Eur J Radiol; 2015 May; 84(5):884-91. PubMed ID: 25650332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis.
    Iwano S; Kamiya S; Ito R; Nakamura S; Naganawa S
    Cancer Imaging; 2021 Jan; 21(1):7. PubMed ID: 33413669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of single-phase dual-energy CT to differentiate vascular and nonvascular incidental renal lesions on portal venous phase: comparison with CT.
    Mastrodicasa D; Willemink MJ; Madhuripan N; Chima RS; Ho AA; Ding Y; Marin D; Patel BN
    Eur Radiol; 2021 Dec; 31(12):9600-9611. PubMed ID: 34114058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.
    Gordic S; Puippe GD; Krauss B; Klotz E; Desbiolles L; Lesurtel M; Müllhaupt B; Pfammatter T; Alkadhi H
    Radiology; 2016 Jul; 280(1):78-87. PubMed ID: 26824712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT.
    Manoharan D; Netaji A; Diwan K; Sharma S
    AJR Am J Roentgenol; 2020 Dec; 215(6):1389-1397. PubMed ID: 33052738
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual-energy perfusion-CT of pancreatic adenocarcinoma.
    Klauss M; Stiller W; Pahn G; Fritz F; Kieser M; Werner J; Kauczor HU; Grenacher L
    Eur J Radiol; 2013 Feb; 82(2):208-14. PubMed ID: 23062281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dual-energy CT post-processing to differentiate venous thrombosis from iodine flux artefacts.
    Weiss J; Schabel C; Othman AE; Bier G; Nikolaou K; Bamberg F; Bongers MN
    Eur Radiol; 2018 Dec; 28(12):5076-5082. PubMed ID: 29869173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
    Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
    Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
    Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Attenuation Difference and Iodine Concentration Thresholds at Rapid-Kilovoltage-Switching Dual-Energy CT for Detection of Enhancement in Renal Masses.
    Sadoughi N; Krishna S; Macdonald DB; Chatelain R; Flood TA; McInnes MDF; Schieda N
    AJR Am J Roentgenol; 2019 Sep; 213(3):619-625. PubMed ID: 31120787
    [No Abstract]   [Full Text] [Related]  

  • 19. Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium.
    Lin YM; Chiou YY; Wu MH; Huang SS; Shen SH
    PLoS One; 2019; 14(7):e0219577. PubMed ID: 31287838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
    Patel BN; Rosenberg M; Vernuccio F; Ramirez-Giraldo JC; Nelson R; Farjat A; Marin D
    AJR Am J Roentgenol; 2018 Sep; 211(3):571-579. PubMed ID: 30040464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.